Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma

INTRODUCTION: Pheochromocytomas and paragangliomas (PPGLs) are highly heritable tumours, with up to 40% of cases carrying germline variants. Current guidelines recommend genetic testing for all patients with PPGLs. Next-generation sequencing (NGS) enables accurate, fast, and inexpensive genetic test...

Descripción completa

Detalles Bibliográficos
Autores principales: Pipitprapat, Weenita, Pattanaprateep, Oraluck, Iemwimangsa, Nareenart, Sensorn, Insee, Panthan, Bhakbhoom, Jiaranai, Poramate, Chantratita, Wasun, Sorapipatcharoen, Kinnaree, Poomthavorn, Preamrudee, Mahachoklertwattana, Pat, Sura, Thanyachai, Tunteeratum, Atchara, Srichan, Kanoknan, Sriphrapradang, Chutintorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317928/
https://www.ncbi.nlm.nih.gov/pubmed/34309460
http://dx.doi.org/10.1080/07853890.2021.1956687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317928/
https://www.ncbi.nlm.nih.gov/pubmed/34309460
http://dx.doi.org/10.1080/07853890.2021.1956687

Ejemplares similares